P1.12B.03 Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK+ NSCLC from the ALTA-1L Trial

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

19

Issue :

10, Number 10 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs67694652

Full Text :

https://doi.org/10.1016/j.jtho.2024.09.362